Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Anaes TopicsNeuromuscular blockade & reversal

Anaes · Neuromuscular blockade & reversal

Neuromuscular monitoring and the train-of-four

Also known as Train-of-four (TOF) monitoring · Peripheral nerve stimulation · Quantitative neuromuscular monitoring · Acceleromyography · Post-tetanic count

Neuromuscular monitoring is the objective assessment of the depth and recovery of a neuromuscular block by delivering a supramaximal electrical stimulus to a peripheral motor nerve and observing the evoked muscle response. The train-of-four — four stimuli at 2 Hz, 0.5 seconds apart — is the workhorse pattern: it yields a TOF count (the number of detectable twitches, 0 to 4) and a TOF ratio (T4 divided by T1). A non-depolarising block shows fade (ratio below 1.0, with sequential loss of T4 then T3 then T2 then T1) whereas a depolarising phase I block shows no fade (all four twitches reduced proportionally, ratio near 1.0). Residual neuromuscular blockade, defined as a TOF ratio below 0.9 at extubation, causes postoperative airway obstruction, aspiration and hypoxia; the 2023 ASA practice guideline recommends quantitative monitoring whenever a neuromuscular blocker is administered, with a confirmed TOF ratio of at least 0.9 before extubation.

high21 referencesUpdated 26 July 202610 min readVerification in progress

Practise this topic

  • 18 MCQs

Your progress

Saved on this device.

Practise this topic18 MCQs with explanations

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA

Red flags

  • Residual neuromuscular blockade (a TOF ratio below 0.9 at extubation) causes airway weakness, aspiration, hypoxia and reintubation — the modern safe threshold for extubation is a TOF ratio of AT LEAST 0.9, not the older 0.7.
  • Subjective (visual or tactile) assessment of train-of-four fade is INSUFFICIENT — it cannot reliably detect residual blockade once the ratio is above about 0.4; always use quantitative (acceleromyography) monitoring whenever a neuromuscular blocker has been given.
  • Confirm a TOF ratio of 0.9 or higher AND clinical criteria (sustained head lift, grip strength) before extubation — do not rely on a single modality.
  • A depolarising (suxamethonium phase I) block shows NO fade on the train-of-four (all four twitches reduced proportionally, ratio near 1.0), whereas a non-depolarising block shows progressive fade — use this to distinguish the two.
  • The facial nerve / orbicularis oculi recovers FASTER than the adductor pollicis — relying on it alone overestimates recovery and risks false reassurance before extubation.
On this page
Study tools

Your progress

Saved on this device.

Practise this topic18 MCQs with explanations

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA

Red flags

  • Residual neuromuscular blockade (a TOF ratio below 0.9 at extubation) causes airway weakness, aspiration, hypoxia and reintubation — the modern safe threshold for extubation is a TOF ratio of AT LEAST 0.9, not the older 0.7.
  • Subjective (visual or tactile) assessment of train-of-four fade is INSUFFICIENT — it cannot reliably detect residual blockade once the ratio is above about 0.4; always use quantitative (acceleromyography) monitoring whenever a neuromuscular blocker has been given.
  • Confirm a TOF ratio of 0.9 or higher AND clinical criteria (sustained head lift, grip strength) before extubation — do not rely on a single modality.
  • A depolarising (suxamethonium phase I) block shows NO fade on the train-of-four (all four twitches reduced proportionally, ratio near 1.0), whereas a non-depolarising block shows progressive fade — use this to distinguish the two.
  • The facial nerve / orbicularis oculi recovers FASTER than the adductor pollicis — relying on it alone overestimates recovery and risks false reassurance before extubation.
The one-line answer

Neuromuscular monitoring is the objective assessment of block depth and recovery by stimulating a peripheral motor nerve and measuring the evoked muscle response. The train-of-four (four stimuli at 2 Hz, 0.5 seconds apart) yields a TOF count (depth, 0 to 4) and a TOF ratio (recovery, T4 divided by T1). Fade is the non-depolarising fingerprint; its absence with globally reduced twitches marks a depolarising block. The safe extubation threshold is a TOF ratio of at least 0.9, confirmed quantitatively — the eye and finger are blind between 0.4 and 0.9. [1]

Meet the patient

A 60-year-old woman is extubated after a three-hour abdominal operation. She obeys commands, opens her eyes, and lifts her head for five seconds. The felt TOF count is 4 with no perceptible fade. Three minutes later she obstructs, desaturates, and needs reintubation. Her true TOF ratio was 0.6.[1]

The dangerous range of residual blockade — a TOF ratio of 0.4 to 0.9 — is precisely range human eye and finger cannot perceive. The entire apparatus of monitoring exists to close that blind spot. Hold one principle: the monitor decides, not the eye.[1][14]

Anaesthesia Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship library.

Sign in to continueSee pricing
References21ShowHide
  1. [1]Thilen SR, et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology, 2023.PMID 36520073
  2. [2]Tao JC, et al. Current status of neuromuscular reversal and neuromuscular monitoring in China: a cross-sectional survey BMC Anesthesiol, 2026.PMID 42185770
  3. [3]Krönauer T, et al. [Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice]. Anaesthesiologie, 2026.PMID 42334564
  4. [4]Felix F, et al. Recurarization in the Post-anesthesia Care Unit One Hour After Sugammadex Administration: A Case Report Cureus, 2026.PMID 42306367
  5. [5]Jia X, et al. Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double-Blind Randomized Controlled Trial CNS Neurosci Ther, 2026.PMID 42144995
  6. [6]Chen Z, et al. Half-dose neostigmine and low dose sugammadex as a reversal agent for vecuronium: a pilot randomized trial Anaesth Crit Care Pain Med, 2026.PMID 42217574
  7. [7]Leslie K, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial Lancet Respir Med, 2026.PMID 42263720
  8. [8]Blobner M, et al. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data Br J Anaesth, 2020.PMID 31607388
  9. [9]Kirmeier E, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study Lancet Respir Med, 2019.PMID 30224322
  10. [10]Savarese JJ, Ali HH, Murphy JD, et al. Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine Anesthesiology, 1975.PMID 122883
  11. [11]Eriksson LI Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand, 1996.PMID 8792879
  12. [12]Wyon N, Joensen H, Yamamoto Y, Lindahl SG, Eriksson LI Carotid body chemoreceptor function is impaired by vecuronium during hypoxia Anesthesiology, 1998.PMID 9856722
  13. [13]Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium Anesthesiology, 2000.PMID 10754616
  14. [14]Brull SJ, Silverman DG Visual and tactile assessment of neuromuscular fade Anesth Analg, 1993.PMID 8394051
  15. [15]Brull SJ, Silverman DG Visual assessment of train-of-four and double burst-induced fade at submaximal stimulating currents Anesth Analg, 1991.PMID 1952146
  16. [16]Drenck NE, Ueda N, Olsen NV, Engbaek J, Jensen E, Skovgaard LT, Viby-Mogensen J Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four Anesthesiology, 1989.PMID 2929994
  17. [17]Cammu G, Schepens T, De Neve N, et al. Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study Eur J Anaesthesiol, 2017.PMID 27902641
  18. [18]Fuchs-Buder T, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision Acta Anaesthesiol Scand, 2023.PMID 37345870
  19. [19]Viby-Mogensen J, et al. Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology, 1981.PMID 7294384
  20. [20]Hristovska AM, et al. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev, 2017.PMID 28806470
  21. [21]Chambers D, et al. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment. Br J Anaesth, 2010.PMID 20937718

Test yourself

Practise what you just read

  • 18 MCQs
Anaesthesia Pro

$29/ monthor $279 / year

The complete Anaesthesia library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNeuromuscular blockade & reversalNeuromuscular blockade & reversalNextRocuroniumNeuromuscular blockade & reversal